Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
about
Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the ArtRed cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortalityEfficacy and safety of chemotherapy for newly diagnosed advanced non-small cell lung cancer with venous thromboembolismCharacteristics and Risk Factors of Cancer Associated Venous ThromboembolismPatterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation.A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment.Widely Used Types and Clinical Applications of D-Dimer Assay.The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.VKORC1 -1639 G>A Polymorphism in Romanian Patients With Deep Vein Thrombosis.Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients.Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.Clinical and Prognostic Significance of Lupus Anticoagulant Measurement in Patients With Lung Cancer.[Iron deficiency, thrombocytosis and thromboembolism].Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients.Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to BiologyFrequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerInsights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
P2860
Q26776112-368E8B62-B685-4E27-B8EA-3BBD5AF77429Q34408343-B49B6EAB-6E04-43F7-82D6-E763DCDAEA95Q36247897-74C8D8E8-F653-4AC8-A1C8-A021AEF6EB70Q36276667-326EB1F7-EB0A-4EE8-B052-DE5A2395D60CQ36406741-6A3A71E4-C33E-4F04-8AD3-DC6D22722EEDQ36472966-18C4FFFC-06A7-4343-848B-9A48E767BD4AQ36625405-5251C6DB-52C6-47DD-A673-23555F7B50C7Q37293267-7092AC11-086B-4BB6-A5F9-8524467C9171Q38789567-AC879B82-5078-4662-ABAA-37E793FE534EQ40235024-CD3C9F53-D431-44B4-B535-D1195D0AD1CEQ40938171-1EAFCA9E-EC94-46DE-805D-EC2850608429Q41138580-BAFDE477-05EE-4B9B-9221-85AA5AEB4D28Q42177895-C06ECCBA-0628-4218-A1DE-DD706D154550Q48015257-B35B61E5-CFB2-4C53-96F4-6EE6696F3342Q49951327-89DB2E8D-04AC-423C-824C-F4866101728AQ54434317-07F9D879-100D-4967-93EF-CC8BB90F6936Q54939232-EFF82E3E-83FE-4D82-A0DA-67ACFCFFB41AQ58571133-34047C96-8D37-4051-BF44-39B8DAB011E6Q58777030-B32ED5BF-C371-4D60-9FFB-7A0CAE7D5290Q58803859-CBCC4640-03AA-4F5B-91A4-DD913E306996
P2860
Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors for venous thromb ...... r and Thrombosis Study (CATS).
@en
type
label
Risk factors for venous thromb ...... r and Thrombosis Study (CATS).
@en
prefLabel
Risk factors for venous thromb ...... r and Thrombosis Study (CATS).
@en
P1433
P1476
Risk factors for venous thromb ...... r and Thrombosis Study (CATS).
@en
P2093
Oliver Königsbrügge
P304
P356
10.1016/S0049-3848(14)50007-2
P478
133 Suppl 2
P577
2014-05-01T00:00:00Z